Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Acme Investments Spf Sarl)
Aiforia Technologies Plc, Company release, June 17, 2024 02:30 p.m. EEST
Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Acme Investments Spf Sarl)
Aiforia Technologies Plc has received a notification according to which the total number of Aiforia shares owned by Acme Investments Spf Sarl exceeds the threshold of five (5) percent. According to the announcement, the holding had exceeded the threshold on April 19, 2024.
The notification of exceeding the ownership threshold is retroactive because on April 12, 2024, the Parliament approved a government proposal to amend the Securities Markets Act (HE 3/2024 vp), which extends the reporting requirements for significant ownership and voting rights, as well as the application of provisions related to public tender offers and obligation to make a tender offer, to include multilateral trading facilities alongside regulated markets.
Total positions of Acme Investments Spf Sarl subject to the notification:
| % shares and voting rights | % of shares and voting rights through financial instruments | Total of both in % | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 7.22% | 7.22% | 28,844,467 |
A: Shares and voting rights
| Number of shares and voting rights | % of shares and voting rights | |||
| Class/type of shares, ISIN code | Direct (AML 9:5) | Indirect (AML 9:6 and 9:7) | Direct (AML 9:5) | Indirect (AML 9:6 and 9:7) |
| FI4000507934 | 2,083,946 | 7.22% | ||
| SUBTOTAL | 2,083,946 | 7.22% | ||
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:
| Name | % of shares and voting rights | % of shares and voting rights through financial instruments | Total of both |
| Timo Syrjälä | 7.22 | 7.22 |
Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358405009878
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more at www.aiforia.com